GIACOMELLI, ANDREA
GIACOMELLI, ANDREA
Dipartimento di Scienze Biomediche e Cliniche
Comparing the efficacy and safety of a first-line regimen with emtricitabine/tenofovir alafenamide fumarate plus either bictegravir or dolutegravir: Results from clinical practice
2023 A. Ciccullo, G. Baldin, V. Borghi, L. Oreni, F. Lagi, P. Fusco, A. Giacomelli, C. Torti, G. Sterrantino, C. Mussini, S. Antinori, S. Di Giambenedetto
Update on Mpox: a brief narrative review
2023 S. Antinori, G. Casalini, A. Giacomelli, A.J. Rodriguez-Morales
COVID-19 Vaccine Hesitancy among Unvaccinated Adults: A Cross-Sectional Exploratory Analysis of Vaccination Intentions in Italy Related to Fear of Infection
2023 O. Curzio, L. Cori, F. Bianchi, F. Prinelli, M. Galli, A. Giacomelli, M. Cristina Imiotti, N. Jesuthasan, V. Recchia, F. Adorni
Concomitant diagnosis of sexually transmitted infections and human monkeypox in patients attending a sexual health clinic in Milan, Italy
2023 A. Rizzo, G. Pozza, F. Salari, A. Giacomelli, D. Mileto, M.V. Cossu, A. Mancon, G. Gagliardi, M. Bianchi, V. Micheli, A. Capetti, S. Antinori, M.R. Gismondo, P. Olivieri, A. Lombardi
Analyzing the efficacy and tolerability of dolutegravir plus either rilpivirine or lamivudine in a multicenter cohort of virologically-suppressed PLWHIV
2023 A. Ciccullo, G. Baldin, G. Sterrantino, M.V. Cossu, A. Giacomelli, F. Lagi, D. Farinacci, V. Iannone, R. Anna Passerotto, A.F. Capetti, S. Antinori, C. Mussini, V. Borghi, S. DI GIAMBENEDETTO
Chagas disease prevalence among migrants from El Salvador in Milan: a cross- sectional study of an often-overlooked population
2023 M. Beltrami, R. Grande, A. Giacomelli, F. Sabaini, L. Biondo, M. Longo, S. Grosso, L. Oreni, S. Fadelli, L. Galimberti, A.L. Ridolfo, S. Antinori
Role of multi-site sampling in the diagnosis of human Monkeypox
2023 A. Rizzo, D. Mileto, D. Moschese, C. Candela, A. Mancon, A. Giacomelli, A. Roberto Raccagni, F. Salari, M. Vittoria Cossu, V. Micheli, A. Castagna, G. Rizzardini, A. Lombardi, S. Nozza, M.R. Gismondo
Chagas disease in Italy: an update of epidemiological studies
2023 S. Antinori, A. Giacomelli, F. Sabaini, G. Casalini, A.L. Ridolfo
Characterization and outcomes of difficult-to-treat patients starting modern first-line ART regimens: data from the ICONA cohort
2023 R. Gagliardini, A. Tavelli, S. Rusconi, S. Lo Caputo, V. Spagnuolo, M. Mercedes Santoro, A. Costantini, A. Vergori, F. Maggiolo, A. Giacomelli, G. Burastero, G. Madeddu, E. Quiros Roldan, A. D'ARMINIO MONFORTE, A. Antinori, A. Cozzi-Lepri
Neutralizing antibody titers induced by JYNNEOS vaccine in unrecognized previous mpox virus exposed individuals
2023 D. Moschese, M. Bianchi, M. Vittoria Cossu, F. Salari, A. Giacomelli, A. Rizzo, S. Lazzarin, F. Sabaini, S. Nozza, D. Mileto, A. Gori, S. Antinori, M.R. Gismondo, G. Rizzardini
Comment on: Doravirine plus lamivudine two-drug regimen as maintenance antiretroviral therapy in people living with HIV: a French observational study
2023 A. Giacomelli, M. Vittoria Cossu, D. Moschese, C. Gervasoni
Drug Shortages Highlight the Need for Expanded Treatment Options for Syphilis
2023 S. Lazzarin, A. Giacomelli, D. Moschese, S. Antinori, C. Gervasoni
Evolution of the SARS-CoV-2 epidemic: From genomic surveillance to new health needs
2023 A. Giacomelli, A. Lisa Ridolfo, L. Oreni, G. Rizzardini, S. Antinori
Potential Misleading Interpretation of Molecular Methods in Mpox Infection Control
2023 A. Giacomelli, M. Vittoria Cossu, G. Pozza, D. Moschese
Viral bloodstream detection in mpox patients: An observational multicentric study
2023 A. Rizzo, D. Moschese, B. Trentacapilli, M.V. Cossu, A. Giacomelli, F. Salari, M. Bianchi, A.R. Raccagni, V. Micheli, A. Gori, E. Messina, S. Antinori, M.R. Gismondo, A. Castagna, D. Mileto, G. Rizzardini, A. Lombardi, S. Nozza
Efficacy and tolerability of dolutegravir/lamivudine versus dolutegravir/rilpivirine in switching from a three-drug regimen based on nonnucleoside reverse transcriptase inhibitors: A retrospective cohort study
2023 F. Lagi, A. Giacomelli, V. Borghi, A. Ciccullo, L. Taramasso, G. Madeddu, G. D'Ettorre, A. Giacometti, F. Ducci, A. De Vito, R. Pincino, S. Di Giambenedetto, C. Mussini, S. Antinori, G. Sterrantino
Risk of COVID-19 in-hospital mortality in people living with HIV compared to general population according to age and CD4 strata: data from the Icona network
2023 A. Giacomelli, R. Gagliardini, A. Tavelli, S. De Benedittis, V. Mazzotta, G. Rizzardini, A. Mondi, M. Augello, S. Antinori, A. Vergori, A. Gori, M. Menozzi, L. Taramasso, F. Maria Fusco, A. De Vito, G. Mancarella, G. Marchetti, A. d'Arminio Monforte, A. Antinori, A. Cozzi-Lepri
SARS-CoV-2 viremia and COVID-19 mortality: A prospective observational study
2023 A. Giacomelli, E. Righini, V. Micheli, P. Pinoli, A. Bernasconi, A. Rizzo, L. Oreni, A. Lisa Ridolfo, S. Antinori, S. Ceri, G. Rizzardini
HCV point of care screening in people tested for SARS‐CoV ‐2 in a social‐housing neighbourhood of Milan, Italy
2023 M. Beltrami, G. Pagani, F. Conti, L. Pezzati, G. Casalini, R. Rondanin, A. Prina, A. Zagari, M. Galli, A. Giacomelli
Opportunistic HCV screening in the general population: New insights for a graduated birth cohort approach
2023 F. Conti, M. Beltrami, G. Pagani, A. Giacomelli